Certain identified information has been excluded from the exhibit pursuant to Item 601(a)(6) of Regulation S-K due to personal privacy concerns. Redacted information is indicated by: [***] DEVELOPMENT AGREEMENTDevelopment Agreement • April 1st, 2024 • Cardiol Therapeutics Inc. • Biological products, (no disgnostic substances)
Contract Type FiledApril 1st, 2024 Company IndustryNOW THEREFORE, in consideration of the premises and the mutual covenants and agreements set forth herein, the Parties agree as follows:
Certain identified information has been excluded from the exhibit pursuant to Item 601(a)(6) of Regulation S-K due to personal privacy concerns. Redacted information is indicated by: [***] DEVELOPMENT AGREEMENTDevelopment Agreement • March 29th, 2023 • Cardiol Therapeutics Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 29th, 2023 Company IndustryNOW THEREFORE, in consideration of the premises and the mutual covenants and agreements set forth herein, the Parties agree as follows: